PACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY) Trademark

Trademark Overview


On Tuesday, December 12, 2023, a trademark application was filed for PACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY) with the United States Patent and Trademark Office. The USPTO has given the PACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY) trademark a serial number of 79400685. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, August 17, 2024. This trademark is owned by LIFEARC. The PACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY) trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

Charitable fund raising; charitable collections; organisation of collections; provision of funding for research, education, prevention and treatment of illnesses and human diseases; financial grant services; provision of funding for charities; provision of funding for medical trials; provision of funding for educational and research posts; information and advisory services relating to all the aforesaid; technology transfer services, namely assisting technologies inventors secure appropriate funding to take development forward; technology transfer services, namely managing revenue from partnered or developed intellectual property; all of the aforesaid in relation to medical and health research.

Promoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; providing advisory, consultancy and information services in the field of commercialisation of products and services by identifying routes to market for research; compilation of scientific, medical and clinical information; maintenance, namely updating of information in databases in relation to medical and health research.

Scientific, medical and clinical research services, biotechnology research and analysis, biochemical research and analysis, biological research and analysis, clinical trials, data mining in relation to medical and health research, data security services in relation to medical and health research, data encryption services in relation to medical and health research, database design and development in relation to medical and health research, mathematical modelling in relation to medical and health research, bioinformatics, drug discovery services, laboratory research, computer programming and design services in relation to medical and health research; consultancy services relating to all of the foregoing; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, collection, calibration, analysis a...
pace (pathways to antimicrobial clinical efficacy)

General Information


Serial Number79400685
Word MarkPACE (PATHWAYS TO ANTIMICROBIAL CLINICAL EFFICACY)
Filing DateTuesday, December 12, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, August 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCharitable fund raising; charitable collections; organisation of collections; provision of funding for research, education, prevention and treatment of illnesses and human diseases; financial grant services; provision of funding for charities; provision of funding for medical trials; provision of funding for educational and research posts; information and advisory services relating to all the aforesaid; technology transfer services, namely assisting technologies inventors secure appropriate funding to take development forward; technology transfer services, namely managing revenue from partnered or developed intellectual property; all of the aforesaid in relation to medical and health research.
Goods and ServicesPromoting research in the field of human health and human diseases through the support and coordination of research projects conducted by universities, hospitals, research foundations and businesses; providing advisory, consultancy and information services in the field of commercialisation of products and services by identifying routes to market for research; compilation of scientific, medical and clinical information; maintenance, namely updating of information in databases in relation to medical and health research.
Goods and ServicesScientific, medical and clinical research services, biotechnology research and analysis, biochemical research and analysis, biological research and analysis, clinical trials, data mining in relation to medical and health research, data security services in relation to medical and health research, data encryption services in relation to medical and health research, database design and development in relation to medical and health research, mathematical modelling in relation to medical and health research, bioinformatics, drug discovery services, laboratory research, computer programming and design services in relation to medical and health research; consultancy services relating to all of the foregoing; scientific research and development in the field of medical technology; research on the development and adaptation of health technology and health-related outcomes associated with implementation of health technology; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; conducting clinical trials for diagnostic tests and for pharmaceutical preparations; providing temporary use of non-downloadable web-based computer software for data integration, exchange, and analysis in relation to medical and health research; providing biomedical and scientific information via a global internet web site related to the field of human health and human diseases; technology transfer services namely product design and development, research and development, product development in relation to medical and health research; antibody humanisation services, namely antibody engineering; biopharmaceutical development; biologic assay development; preclinical research; clinical research; clinical trials management; pharmacovigilance, namely monitoring the effects of medical drugs after they have been licensed for use.

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLIFEARC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, July 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 29, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, July 30, 2024ASSIGNED TO EXAMINER
Wednesday, August 7, 2024NON-FINAL ACTION WRITTEN
Thursday, August 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 17, 2024REFUSAL PROCESSED BY MPU
Monday, August 19, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 9, 2024REFUSAL PROCESSED BY IB